File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000492574
- Scopus: eid_2-s2.0-85055625493
- PMID: 30347404
- WOS: WOS:000451724800004
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Novel neural network approach to predict drug-target interactions based on drug side effects and genome-wide association studies
Title | Novel neural network approach to predict drug-target interactions based on drug side effects and genome-wide association studies |
---|---|
Authors | |
Keywords | Drug-target interaction Drug side effect Genome-wide association studies Neural network Principal component analysis |
Issue Date | 2018 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/HHE |
Citation | Human Heredity, 2018, v. 83 n. 2, p. 79-91 How to Cite? |
Abstract | Aims: We propose a novel machine learning approach to expand the knowledge about drug-target interactions. Our method may help to develop effective, less harmful treatment strategies and to enable the detection of novel indications for existing drugs. Methods: We developed a novel machine learning strategy to predict drug-target interactions based on drug side effects and traits from genome-wide association studies. We integrated data from the databases SIDER and GWASdb and utilized them in a unique way by a neural network approach. Results: We validate our method using drug-target interactions from the STITCH database. In addition, we compare the chemical similarity of the predicted target to known targets of the drug under consideration and present literature-based evidence for predicted interactions. We find drug combination warnings for drugs we predict to target the same protein, hinting to synergistic effects aggravating harmful events. This substantiates the translational value of our approach, because we are able to detect drugs that should be taken together with care due to common mechanisms of action. Conclusion: Taken together, we conclude that our approach is able to generate a novel and clinically applicable insight into the molecular determinants of drug action. |
Persistent Identifier | http://hdl.handle.net/10722/278117 |
ISSN | 2023 Impact Factor: 1.1 2023 SCImago Journal Rankings: 0.483 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Prinz, J | - |
dc.contributor.author | Koohi-Moghadam, M | - |
dc.contributor.author | Sun, H | - |
dc.contributor.author | Kocher, JPA | - |
dc.contributor.author | Wang, J | - |
dc.date.accessioned | 2019-10-04T08:07:49Z | - |
dc.date.available | 2019-10-04T08:07:49Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Human Heredity, 2018, v. 83 n. 2, p. 79-91 | - |
dc.identifier.issn | 0001-5652 | - |
dc.identifier.uri | http://hdl.handle.net/10722/278117 | - |
dc.description.abstract | Aims: We propose a novel machine learning approach to expand the knowledge about drug-target interactions. Our method may help to develop effective, less harmful treatment strategies and to enable the detection of novel indications for existing drugs. Methods: We developed a novel machine learning strategy to predict drug-target interactions based on drug side effects and traits from genome-wide association studies. We integrated data from the databases SIDER and GWASdb and utilized them in a unique way by a neural network approach. Results: We validate our method using drug-target interactions from the STITCH database. In addition, we compare the chemical similarity of the predicted target to known targets of the drug under consideration and present literature-based evidence for predicted interactions. We find drug combination warnings for drugs we predict to target the same protein, hinting to synergistic effects aggravating harmful events. This substantiates the translational value of our approach, because we are able to detect drugs that should be taken together with care due to common mechanisms of action. Conclusion: Taken together, we conclude that our approach is able to generate a novel and clinically applicable insight into the molecular determinants of drug action. | - |
dc.language | eng | - |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/HHE | - |
dc.relation.ispartof | Human Heredity | - |
dc.rights | Human Heredity. Copyright © S Karger AG. | - |
dc.subject | Drug-target interaction | - |
dc.subject | Drug side effect | - |
dc.subject | Genome-wide association studies | - |
dc.subject | Neural network | - |
dc.subject | Principal component analysis | - |
dc.title | Novel neural network approach to predict drug-target interactions based on drug side effects and genome-wide association studies | - |
dc.type | Article | - |
dc.identifier.email | Sun, H: hsun@hku.hk | - |
dc.identifier.authority | Sun, H=rp00777 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1159/000492574 | - |
dc.identifier.pmid | 30347404 | - |
dc.identifier.scopus | eid_2-s2.0-85055625493 | - |
dc.identifier.hkuros | 306284 | - |
dc.identifier.volume | 83 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 79 | - |
dc.identifier.epage | 91 | - |
dc.identifier.isi | WOS:000451724800004 | - |
dc.publisher.place | Switzerland | - |
dc.identifier.issnl | 0001-5652 | - |